SCHEMBL16019276

SCHEMBL16019276

Cc1ccc(-c2nc(C)nc(-c3ccc(C)cc3C)n2)c(C)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
MAPT P10636 4/20 0.40
GAA P10253 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
TP53 P04637 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
ALDH1A1 P00352 2/20 0.39
HPGD P15428 2/20 0.39
KDM4E B2RXH2 1/20 0.39
CYP1A2 P05177 4/20 0.39
CYP2A6 P11509 3/20 0.39
NPSR1 Q6W5P4 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
ALPL P05186 2/20 0.38
LMNA P02545 1/20 0.38
CA9 Q16790 1/20 0.38
FGFR1 P11362 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29354045 0.93 NPC1 (0.47) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL1245257 0.93 NPC1 (0.47) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL14264450 0.89 NPC1 (0.38) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL15599734 0.85 L3MBTL1 (0.59) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL6842063 0.83 NPC1 (0.41) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL15894216 0.83 RAB9A (0.49) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL1245251 0.83 NPC1 (0.41) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL22207363 0.83 TP53 (0.45) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL22207162 0.83 RAB9A (0.47) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL19901679 0.83 NPC1 (0.49) NPC1RAB9AMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170040548-A1 DIPHENYLIMIDAZOLE-FUSED, SPIRALLY CONFIGURED CIS-STILBENE/FLUORENE HYBRID COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME NICHEM FINE TECHNOLOGY CO., LTD. (TW) 2017-02-09 US disclosed
US-20170040547-A1 SPIRALLY CONFIGURED CIS-STILBENE/FLUORENE HYBRID COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME NICHEM FINE TECHNOLOGY CO., LTD. (TW) 2017-02-09 US disclosed
US-9502664-B2 4H-imidazo[1,2-a]imidazoles for electronic applications UDC IRELAND LIMITED (IE) 2016-11-22 US disclosed
US-9502664-B2 4H-imidazo[1,2-a]imidazoles for electronic applications UDC IRELAND LIMITED (IE) 2016-11-22 US disclosed
EP-2776443-B1 4H-IMIDAZO[1,2-A]IMIDAZOLES FOR ELECTRONIC APPLICATIONS BASF SE (DE) 2016-02-03 EP disclosed
US-20140252280-A1 4H-IMIDAZO[1,2-A]IMIDAZOLES FOR ELECTRONIC APPLICATIONS BASF SE (DE) 2014-09-11 US disclosed
US-20140252280-A1 4H-IMIDAZO[1,2-A]IMIDAZOLES FOR ELECTRONIC APPLICATIONS BASF SE (DE) 2014-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170040547-A1 SPIRALLY CONFIGURED CIS-STILBENE/FLUORENE HYBRID COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME SLCO2B1, SLCO4C1, SLCO1B1 NPC1 284/4885RAB9A 767/4885MEN1 4396/4885
US-20170040548-A1 DIPHENYLIMIDAZOLE-FUSED, SPIRALLY CONFIGURED CIS-STILBENE/FLUORENE HYBRID COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME SLCO4C1, SLCO2B1, SLCO1B1 NPC1 215/4885RAB9A 1388/4885MEN1 4639/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.